- Entry: 2026-04-07 @ $164.84 | Current: $137.29 | Loss: -16.7% (-$322.34) - Thesis Conviction: 5/10 → 4/10 (downgraded) - Current Assessment: HOLD with reduced conviction — exit on clarity --- 1. IS THE ORIGINAL THESIS INTACT? Short answer: No. Fractured, not broken — but the cracks are load-bearing. My original conviction rested on a single macro call: *the Iran war premium embedded in oil prices would outlast consensus expectations, producing durable margin accretion for integrated majors like XOM.* Clean logic. Wrong outcome. What unraveled it: - The Iran ceasefire (announced 2026-06-18) killed the war premium I was riding - Brent normalized from $115+ peaks back into the $90–95 range — faster and harder than I modeled - XOM's Q1 2026 earnings (filed 2026-05-04) printed diluted EPS of $1.00 for the quarter against a full-year 2025 run rate of $6.70/share — a compression that should have set off alarms The real mistake: I conflated *cyclical oil price volatility* with *durable earnings power*. The market made that distinction. I didn't. --- 2. WHAT HAS SURPRISED ME? Three surprises — one of them embarrassing. A. Accrual Quality Was Deteriorating Right in Front of Me From XOM's 2026-03 10-Q filing : - Assets grew 3.4% (2026-03: $464.4B vs. 2025-12: $449.0B ) - Diluted EPS collapsed 85% ($1.00 Q1 vs. $6.70 full-year 2025 run rate) Assets expanding while earnings implode is a classic accrual quality red flag — working capital inflating faster than cash generation. I saw the numbers. I didn't interrogate them. That's on me. B. The Insider Selling Was a Signal, Not Noise The transaction record is hard to dismiss in hindsight: - 2026-05-20: XOM SELL 16,600,000 shares — a block sale, not a blip - 2026-03-16: Talley Darrin L (executive) SELL 1,080 shares - 2026-03-02: Talley Darrin L SELL 2,150 shares Management was liquidating into strength *before* the ceasefire hit. I filed this away as routine rebalancing. It wasn't. C. The Fed's

Research these companies